GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (NAS:NEUP) » Definitions » Cash Received from Insurance Activities

NEUP (Neuphoria Therapeutics) Cash Received from Insurance Activities


View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Neuphoria Therapeutics Business Description

Industry
Traded in Other Exchanges
N/A
Address
100 Summit Dr, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.